Suppr超能文献

青少年抑郁症治疗研究延续与维持治疗期间持续缓解的达成与维持

Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy.

作者信息

Rohde Paul, Silva Susan G, Tonev Simon T, Kennard Betsy D, Vitiello Benedetto, Kratochvil Christopher J, Reinecke Mark A, Curry John F, Simons Anne D, March John S

机构信息

Oregon Research Institute, 1715 Franklin Blvd, Eugene, OR 97403-1983, USA.

出版信息

Arch Gen Psychiatry. 2008 Apr;65(4):447-55. doi: 10.1001/archpsyc.65.4.447.

Abstract

CONTEXT

The Treatment for Adolescents With Depression Study evaluated fluoxetine (FLX), cognitive behavioral therapy (CBT), and FLX/CBT combination (COMB) vs pill placebo in 439 adolescents with major depressive disorder. Treatment consisted of 3 stages: (1) acute (12 weeks), (2) continuation (6 weeks), and (3) maintenance (18 weeks).

OBJECTIVE

To examine rates of achieving and maintaining sustained response during continuation and maintenance treatments.

DESIGN

Randomized controlled trial. Response was determined by blinded independent evaluators.

SETTING

Thirteen US sites.

PATIENTS

Two hundred forty-two FLX, CBT, and COMB patients in their assigned treatment at the end of stage 1.

INTERVENTIONS

Stage 2 treatment varied based on stage 1 response. Stage 3 consisted of 3 CBT and/or pharmacotherapy sessions and, if applicable, continued medication.

MAIN OUTCOME MEASURES

Sustained response was defined as 2 consecutive Clinical Global Impression-Improvement ratings of 1 or 2 ("full response"). Patients achieving sustained response were classified on subsequent nonresponse status.

RESULTS

Among 95 patients (39.3%) who had not achieved sustained response by week 12 (29.1% COMB, 32.5% FLX, and 57.9% CBT), sustained response rates during stages 2 and 3 were 80.0% COMB, 61.5% FLX, and 77.3% CBT (difference not significant). Among the remaining 147 patients (60.7%) who achieved sustained response by week 12, CBT patients were more likely than FLX patients to maintain sustained response through week 36 (96.9% vs 74.1%; P = .007; 88.5% of COMB patients maintained sustained response through week 36). Total rates of sustained response by week 36 were 88.4% COMB, 82.5% FLX, and 75.0% CBT.

CONCLUSIONS

Most adolescents with depression who had not achieved sustained response during acute treatment did achieve that level of improvement during continuation and maintenance therapies. The possibility that CBT may help the subset of adolescents with depression who achieve early sustained response maintain their response warrants further investigation.

TRIAL REGISTRATION

clinicaltrials.gov Identifier: NCT00006286.

摘要

背景

青少年抑郁症治疗研究评估了氟西汀(FLX)、认知行为疗法(CBT)以及氟西汀/认知行为疗法联合治疗(COMB)与丸剂安慰剂对439名重度抑郁症青少年的疗效。治疗包括3个阶段:(1)急性期(12周),(2)延续期(6周),以及(3)维持期(18周)。

目的

研究在延续期和维持期治疗中实现并维持持续缓解的比例。

设计

随机对照试验。缓解情况由独立的盲法评估者判定。

地点

美国13个研究点。

患者

在第1阶段结束时,242名接受指定治疗的氟西汀、认知行为疗法和联合治疗的患者。

干预措施

第2阶段的治疗根据第1阶段的缓解情况而有所不同。第3阶段包括3次认知行为疗法和/或药物治疗疗程,如适用,继续用药。

主要结局指标

持续缓解定义为连续2次临床总体印象改善评分为1或2(“完全缓解”)。达到持续缓解的患者根据后续的未缓解状态进行分类。

结果

在第12周时尚未达到持续缓解的95名患者(39.3%)中(联合治疗组29.1%,氟西汀组32.5%,认知行为疗法组57.9%),第2阶段和第3阶段的持续缓解率分别为联合治疗组80.0%,氟西汀组61.5%,认知行为疗法组77.3%(差异无统计学意义)。在第12周时达到持续缓解的其余患者147名(60.7%)中,认知行为疗法组患者比氟西汀组患者更有可能在第36周时维持持续缓解(96.9%对74.1%;P = 0.007;联合治疗组88.5%的患者在第36周时维持持续缓解)。到第36周时,联合治疗组、氟西汀组和认知行为疗法组的总体持续缓解率分别为88.4%、82.5%和75.0%。

结论

大多数在急性期治疗中未达到持续缓解的抑郁症青少年在延续期和维持期治疗中确实达到了该改善水平。认知行为疗法可能有助于在早期达到持续缓解的抑郁症青少年亚组维持缓解这一可能性值得进一步研究。

试验注册

clinicaltrials.gov标识符:NCT00006286。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验